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Massive blood loss may be defined as loss of one blood volume in 24 hours, or 50% of blood volume during 3 hours of surgery (Stainsby et al, 2000; Blain and Paterson, 2016). The initial 
physiological response is increased sympathetic tone, which 
maintains arterial blood pressure and perfusion to vital organs. 
However, once the physiological reserve has been reached, 
hypoperfusion will decrease the delivery of oxygen and nutrients 
to the tissues. This will cause both hyperlactaemia and a cascade 
of inflammatory responses (Gaunt and Woolley, 2014). This leads 
to the development of coagulopathies, systemic inflammatory 
response syndrome (SIRS) and ultimately cardiac arrest (Gaunt 
and Woolley, 2014). 
Assessment of haemorrhage during surgery can be difficult, 
because anaesthesia can attenuate the physiological responses to 
haemorrhage, and because blood loss calculations may be inaccurate 
and often underestimate blood loss. Careful monitoring of blood 
loss (volume in the suction canister and weight of swabs) is essential. 
Cardiovascular responses to fluid administration, such as pulse 
pressure variation or systolic pressure variation, can be a good 
indicator of blood loss (Bickell et al, 1994; Drozdzynska et al, 2018). 
The aims when managing an animal during haemorrhage are to 
restore oxygen delivery to the tissues, improve circulating volume 
and achieve haemostasis. The optimal fluid to use in the initial 
management of haemorrhage is controversial. Both crystalloids 
and colloids are effective in correcting hypotension, although 
administration of large volumes may lead to haemodilution, 
hypothermia, acidosis and coagulopathies (Cullen, 2012; Gaunt 
and Woolley, 2014; Chodan and Davidow, 2015; Grimm, 2015). 
Importantly, blood products (packed red blood cells (pRBC) 
and whole blood) are the only fluids to provide oxygen carrying 
capacity. There is clinical evidence in humans to suggest that 
administration of blood products compared to crystalloid 
resuscitation in the face of massive blood loss maintains endothelial 
integrity and reduces SIRS, coagulopathies and the need for 
volume (Gaunt and Woolley 2014). However, blood transfusions 
in people are associated with increased mortality, postoperative 
infection, and sepsis (Stainsby et al, 2000). In a retrospective 
study (953 transfusions in dogs), there was a 15% incidence of 
transfusion reactions, most commonly fever and vomiting (Bruce 
et al, 2015). Mortality rates were less than 1%, with dogs usually 
dying from an underlying disease process rather than as a direct 
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result of blood product administration (Bruce et al, 2015). If blood 
products are used, there are logistical considerations with stock 
availability, requirements for early blood typing, and organisation 
within the veterinary hospital, as well as the cost of the products.
Case description 
A 2-year-old male neutered American Staffordshire Terrier, 
weighing 30 kg, was presented with tachycardia, dyspnoea 
and acute collapse with pale mucous membranes. He had been 
presented to the hospital 2 weeks previously with a haemothorax 
and similar clinical signs. At that time, computerised tomography 
(CT) revealed a right thoracic mass, considered most likely to be 
a thymic involution causing haemorrhage. He improved following 
fluid therapy and rest, and was discharged from the hospital.
At re-presentation, manual packed cell volume (PCV) and total 
solids (TS) were 45% and 52 g/l respectively. A blood smear revealed 
mild thrombocytopenia, which was interpreted as being due to 
increased platelet consumption in the face of haemorrhage. On 
thoracic focused assessment with sonography for trauma (TFAST) 
a small amount of free fluid was seen, but the volume was too small 
to sample. Intravenous (IV) fluid therapy (Hartmann’s solution) 
was started, and a nasal cannula was fitted for administration 
of oxygen. Overnight the dog became tachypnoeic, tachycardic 
(160–200  beats per minute (bpm)), and his oxygen saturation 
(SpO2) dropped to 90%. Ongoing intrathoracic haemorrhage was 
suspected, and confirmed by thoracocentesis, which yielded a 
sample with a PCV of 36% and TS of 52 g/l. This matched a blood 
sample taken from his jugular vein. Radiographs revealed a large 
mass in the right thorax. Within a few hours his PCV had dropped 
to 22% and TS to 42 g/l. Coagulation tests were normal (activated 
partial thromboplastin time (APTT) 88 seconds, prothrombin 
time (PT) 155 seconds). He was blood typed (DEA 1.1 negative) 
and given half a unit of pRBC. Due to the continued blood loss 
and lack of clinical improvement, emergency surgical resection of 
the mass via a sternotomy was planned.
Both cephalic veins were cannulated. The pre-anaesthetic 
clinical examination revealed a pulse rate of 120 bpm synchronous 
with the heart, hyperdynamic peripheral pulses, pale mucous 
membranes and a capillary refill time (CRT) of <3 seconds. The 
dog was tachypnoeic, and required supplementation of inspired 
oxygen to maintain his SpO2 above 90%. 
Methadone (0.3 mg/kg IV) was administered and a facemask 
used for preoxygenation. Anaesthesia was induced IV with 
ketamine (0.5 mg/kg) followed by alfaxalone given to effect 
(1.5 mg/kg required). After endotracheal intubation with a 
cuffed tube, intermittent positive pressure ventilation (IPPV) 
was started using a Nuffield 200 Ventilator with a flow rate set at 
0.3 L/s, inspiratory time of 1 second, expiratory time of 4 seconds 
and peak inspiratory pressure (PIP) of 12 cmH2O. Antibiotics 
(cefuroxime) were given before the start of surgery and every 
90 minutes thereafter. General anaesthesia (GA) was maintained 
with sevoflurane vaporised in oxygen, using a rebreathing system 
(circle). In addition to visual monitoring of respiratory rate 
and tactile monitoring of pulse quality, monitoring was carried 
out using electrocardiography, pulse oximetry, capnography, 
oesophageal temperature, and non-invasive arterial blood pressure 
measurement (oscillometric) until cannulation of the right 
dorsal pedal artery with a 22 G catheter enabled direct arterial 
blood pressure measurement. The first arterial blood gas (ABG) 
(Table 1, column A) revealed an acidaemia, respiratory acidosis, 
severe hypoxaemia and a haemoglobin concentration of 8 g/dL. 
Hartmann’s solution was administered IV at a rate of 10 mL/kg/h 
and tranexamic acid (10 mg/kg) was given IV.
In theatre, a GE Aespire S5 Anesthesia Machine with 7900 
Smartvent was used on a volume-controlled pressure limited mode: 
a tidal volume (TV) was set a 10 mL/kg, inspiration:expiration 
ratio of 1:2, respiratory rate (RR) at 12, PIP at 20 mmHg and 
positive end expiratory pressure (PEEP) 0 mmHg. Continuous 
rate infusions (CRI) of ketamine (10 μg/kg/minute) and fentanyl 
(10 μg/kg/h) were started. A second ABG (Table 1, column B) 
just before start of the sternotomy revealed an acidaemia with a 
hyperlactaemia, but an improved partial pressure of oxygen with a 
haemoglobin of 6 g/dL.
As surgery began, the heart rate (HR) and mean arterial 
pressure (MAP) increased from 100 to 160 bpm and from 85 to 
110 mmHg respectively. The changes were interpreted as responses 
to nociception, therefore sequential boluses of 3 μg/kg of fentanyl 
(12 μg/kg total) were administered and the ketamine CRI was 
Table 1. Arterial blood sample values at different 
times
A B C D
pH (7.35–7.45) 7.287 7.283 7.340 7.123
PaCO
2
  35–45 mmHg) 53.1 45.6 44.3 76.4
PaO
2
  (80–500 mmHg) 70.9 240 374 247.1
HCO
3
- (20–24 mmol/L) 24.8 21.1 23.4 24.4
Base excess (- 5–0 ) -1.9 -5.1 -2.1 -5.3
Sp0
2
 (90–100%) 91.7 99.9 99.7 99.5
Na+ (139–150 mmol/L) 140.4 140 140.1 140.3
K+ (3.4–4.9 mmol/L) 3.37 3.61 3.2 2.88
Ca++ (1.12–1.4 mmol/L) 1.33 1.15 0.74 1.18
Cl– (106–127 mmol/L) 111 112 114 115
Anion gap (8–25 mmol/L) 8 10.5 5.9 3.7
Haematocrit (35–50%) 24 18 13 26
Total haemoglobin (12–17 g/dL) 8 6 4.4 8.9
Glucose (3.3–6.4 mmol/L) 6.5 8.2 7.8 6.5
Lactate (0.6–2.0 mmol/L) 6.5 4.22 2.5 1.35
A,B,C,D correspond to time points in minutes during the general anaesthesia 
(GA); A = T20 (20 minutes after initiation of GA), B = T90, C = T180, D = T240
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Discussion 
It was estimated that the dog lost his entire blood volume during 
the 3  hours of surgery, which is considered to be a massive 
haemorrhage (Table 2). The published UK guidelines for people 
emphasise the importance of restoring blood volume to maintain 
tissue perfusion and oxygenation; and of achieving haemostatis 
by treating the source of bleeding and permitting coagulation 
(Stainsby et al, 2000; Kisielewicz and Self, 2014). There is no 
evidence for the optimal fluid and timing of administration for 
dogs when treating acute haemorrhage (Jutkowitz et al, 2002; 
Kwan et al, 2014). The dog initially received a large volume of 
crystalloids and colloids in response to tachycardia, hypotension 
and increased serum lactate, which are indicators of hypoperfusion 
and inadequate delivery of oxygen to the organs (Table 3). These 
fluids are effective at correcting hypotension, but can lead to 
acidosis, hypothermia and coagulopathy. Furthermore, they 
do not provide oxygen carrying capacity and although they can 
improve microcirculatory perfusion by reducing blood viscosity, 
they can exacerbate the failure of oxygen delivery to the tissues by 
diluting the residual erythrocytes. 
In response to fluid therapy the dog’s vital parameters (HR, MAP, 
lactate) improved, but the haemoglobin concentration dropped to 
4.4 g/dL. There is no consensus in the veterinary literature about 
when to administer blood products based on haemoglobin levels. 
In people, current guidelines from the American Association 
of Blood Banks (AABB) have a conservative approach to blood 
transfusion, with a transfusion not given until haemoglobin 
falls below a ‘trigger’ of 7 g/dL rather than 8–9 g/dL (Carson et 
al, 2016). This level was based on 31 randomised control trials 
(RCT) showing that a conservative RBC transfusion threshold 
was not associated with higher rates of adverse clinical outcome, 
increased to 20 μg/kg/min. This reduced the heart rate (90 bpm) 
and MAP (65 mmHg). Once the thorax was opened, severe active 
bleeding was seen. The heart rate increased to 180 bpm and the 
MAP decreased to 50 mmHg. Two boluses of 10 mL/kg Hartmann’s 
solution and one gelatin based colloid bolus (Geloplasma, 
Fresenius Kabi, Runcorn) of 15 mL/kg were administered while 
blood products were prepared for administration. Blood pressure 
and heart rate (HR) returned to values seen after induction of GA. 
Due to the position of the mass in the dorsal thorax, the surgeons 
closed the sternotomy and started a right lateral thoracotomy. At 
the end of the first surgery, a 50% blood volume loss was estimated 
using the measurements described in Table 2. Packed red blood 
cells and fresh frozen plasma (FFP), one unit each and both DEA 
1.1 negative, were administered at an initial rate of 0.5 mL/kg 
for 10 minutes, although due to the massive blood loss this was 
rapidly increased to 60 mL/kg/h. Once the thoracic cavity was 
entered for second surgery, the dog became mildly hypotensive 
and tachycardic (MAP 55 mmHg, HR 130 bpm). Three fluid 
boluses of 10 mL/kg Hartmann’s solution improved the MAP and 
reduced the HR. An ABG (Table 1, C) revealed an improved pH 
with mild acidaemia, an improved hyperlactaemia, hypocalcaemia 
and hypokalaemia, with a severely low haemoglobin. Given the 
continuing blood loss, low haemoglobin concentration and no 
further DEA 1.1 negative products being available, the decision 
was made to administer a unit of DEA 1.1 positive pRBC. No 
immediate haemolytic reactions or anaphylaxis were seen. During 
the last 30 minutes of the surgery, the HR decreased from 100 to 
40–50 bpm and MAP was 75 mmHg. Although a heat mat (at 39°C) 
was placed under the dog during the procedure, the dog’s body 
temperature dramatically reduced from the start of the surgery, to 
between 32–34°C by the end of surgery. A thoracostomy tube was 
placed. During the skin closure, the ketamine CRI was reduced to 
10 μg/kg/min and the fentanyl to 5 μg/kg/h. 
During the surgery, haemoglobin oxygen saturation was 
maintained above 95% and no arrhythmias were observed. 
At the end of surgery, fluid loss equivalent to 100% blood 
volume loss was estimated (Table 2). During this time, the dog had 
received a total volume of 3750 mL of fluids (Table 3). 
At the end of surgery, sevoflurane administration was 
discontinued and spontaneous ventilation resumed. The dog 
was transferred to the Intensive Care Unit (ICU) while receiving 
oxygen via the endotracheal tube, and this was continued in the 
ICU. A urinary catheter was placed. The fourth ABG, with the 
trachea still intubated (Table  1, column D) revealed significant 
acidaemia with a severe respiratory acidosis, an improved 
ionised calcium, hypokalaemia, normal lactate and an improved 
haemoglobin. The manual PCV was 33% and TS 32 g/L. 
Postoperative analgesia was give: ketamine CRI at 10 μg/kg/min, 
fentanyl 5 μg/kg/h and paracetamol 10 mg/kg IV every 8  hours. 
Hartmann’s solution supplemented with 28 mmol/L potassium 
chloride was administered (4 mL/kg/hr) and tranexamic acid 
(10 mg/kg IV every 8 hours). Recovery from anaesthesia was 
smooth, and the dog was discharged from the hospital 5 days later. 
Unfortunately, histopathology performed on the biopsies 
of the mass revealed an aggressive soft tissue cell sarcoma, and 
euthanasia was performed by the referring veterinary surgeon. 
Table 2. Theatre blood loss record from this dog 
during general anaesthesia 
Total 
weight of 
swabs (g)
(A)
Number 
of swabs
(B)
Weight of 
dry swabs 
(g)
(C)
Volume of 
blood (mL)
(1g = 1 mL)
(= A – C)
Small swabs  
(6 g each) 
(D)
208 21 126 82
Laparotomy swabs 
(20 g each)
(E)
1411 22 440  971
Amount contained within suction                 + 1650
Estimated amount on drapes                                             + 10
Volume of saline used in surgery (e.g. to clear the  
operating field)                                                                   – 15
Total blood loss (mL)                                                          = 2698
Estimated percentage of blood volume* lost  
(total blood loss/estimated blood volume x 100)
100%
*Estimated blood volume calculated as 90 mL/kg (dog)
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mortality or post-operative complications (Lier et al, 2008). 
Recommendations for resuscitation from haemorrhagic shock in 
people advocate a 1:1 ratio of FFP:pRBC to restore the lost blood 
cells and coagulation factors (Gaunt and Woolley, 2014). During 
the surgery the dog received non-compatible blood products. The 
clinical decision to give incompatible blood was based on severe 
ongoing haemorrhage, a very low haemoglobin concentration 
(4.4 g/dL) and evidence of inadequate oxygen delivery and 
increased anaerobic respiration (lactate >2 mmol/L). The benefits 
and needs were considered to be greater than the risk of acute 
haemolytic reaction and anaphylaxis (Chodan and Davidow, 
2015; Redding and Plews, 2016); furthermore, since dogs lack 
isoantibodies, the first transfusion is unlikely to cause an immune 
reaction. Fresh whole blood would have been more appropriate 
and ideally would have been gven in this situation, as this includes 
platelets, which are not found in pRBC or FFP. 
Using a cell salvage device to permit autologous blood 
transfusion might have been a useful strategy in this case. The 
KEY POINTS
zz Massive blood loss, defined as more than 50% blood volume in three 
hours, leads to physiological responses including increased sympathetic 
tone and tachycardia. 
zz Normal physiological responses may be masked during anaesthesia, so 
anticipating surgical haemorrhage, careful monitoring of blood loss, and 
communication with the surgeons are essential. 
zz Management of blood loss should be based on the amount of 
volume lost and the patient’s physiological response, with the 
aim of maintaining the circulating volume, tissue oxygen delivery 
and haemostasis. 
zz It is important to know the implications of the treatments: large 
volumes of crystalloids (such as Hartmann’s solution) may result in 
haemodilution, electrolyte imbalances and coagulopathies, while 
administration of blood products can cause transfusion reactions. 
zz Volume replacement and maintaining oxygen carrying capacity are the 
priorities during acute blood loss, but the consequences of rapid fluid 
replacement, such as electrolyte abnormalities, coagulopathies and 
hypothermia, also need to be monitored and treated.
autologous RBC have antigenic compatibility and have not 
undergone cellular associated changes to reduced function and 
duration (oxygen delivery capacity). The use of a cell salvage 
device might also have reduced costs associated with pRBC 
transfusion (Kellett-Gregory et al, 2013). In people, their use is 
rarely associated with complications apart from coagulopathies 
and electrolytes abnormalities (Esper and Waters, 2011; 
Kellett-Gregory et al, 2013). The presence of neoplasia in this case 
complicates the decision on whether to use cell salvage techniques. 
There is the theoretical potential for disseminating neoplastic 
cells via the vascular system, although controlled trials have not 
reported an increase in metastasis or mortality compared to 
transfusions of previously-collected  autologous blood (Esper and 
Waters, 2011). Retrospectively, since we had access to a limited 
immediate supply of blood products, and in view of the size of 
the dog and the high risk of bleeding, using a cell salvage device 
should have been considered. 
Hypocalcaemia and hypokalaemia were observed after 
transfusion of two units of pRBC and one unit of FFP alongside 
the administration of Hartmann’s solution and gelatin based 
colloids. This can be caused by dilutional effects, citrate overload, 
hypoproteinemia and re-entry of electrolytes into transfused 
cells (Blain and Paterson, 2016). There were no changes on 
the electrocardiogram, such as a prolonged QT interval or 
inversion of the T wave (Chodan and Davidow, 2015). Calcium 
is important in coagulation, contractility and heart rate. 
Reduced activation of coagulation on platelets and disruption 
of haemostatis is clinically evident if the ionised calcium falls 
below 0.6 mmol/L and the pH  below 7.3 (Lier et al, 2008). The 
low calcium may have contributed to the bradycardia at the end 
of surgery, although this is likely to have been multifactorial, 
in combination with severe hypothermia, bradycardia due to 
myocardial hypoxia, and reduced nociceptive stimuli (Korner 
and Edwards, 1960; Grimm, 2015). The calcium levels returned 
to normal by 1 hour after recovery from anaesthesia, while 
the potassium continued to decrease, so the dog’s crystalloid 
fluids were supplemented with potassium chloride. Due to the 
complexity of the case and concerns regarding the potential for 
accidental administration of fluid containing excessive amounts 
of electrolytes, potassium and calcium were not administered 
intraoperatively, although retrospectively responding to these 
electrolyte abnormalities more rapidly may have been beneficial. 
A more proactive approach to the management of electrolyte 
abnormalities in animals receiving large volumes of fluids and 
blood products will be adopted in the future.
Tranexamic acid (TA) is an antifibrinolytic drug. In people 
there is evidence that when administered during active bleeding 
it reduces blood loss and requirements for blood transfusion 
(Blain and Paterson, 2016). Tranexamic acid has been evaluated in 
healthy dogs and has been reported to be safe at clinical doses of 
10 mg/kg (Kelmer et al, 2013). Assessment of its anti-fibrinolytic 
properties using thromboelestography were inconsistent (Kelmer 
et al, 2013; Kelmer et al, 2015). A retrospective evaluation of the 
efficacy on TA in bleeding dogs showed that dogs receiving TA 
received less volume of blood products than those that were not 
treated with this drug (Kelmer et al, 2015). Prospective studies are 
Table 3. Fluid replacement in this dog during acute 
blood loss during general anaesthesia 
Hartmann’s solution 2000 mL 66.6 mL/kg
Gelatin-based colloid 500 mL 16.6 mL/kg
pRBC DEA 1.1 + 350 mL 11.6 mL/kg
pRBC DEA 1.1 - 550 mL 18.3 mL/kg
FFP 350 mL 11.6 mL/kg
Total volume replacement 3750 mL 125 mL/kg
FFP: fresh frozen plasma. pRBC: packed red blood cells
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warranted to determine its efficacy intraoperatively. Because of its 
potential benefits and apparent absence of adverse effects in dogs, 
TA is being used more commonly in veterinary medicine. 
Conclusions 
This case was challenging and underlines the need for further 
studies and consensus in dealing with massive blood loss. 
Retrospectively, the dog could have benefitted from 
supplementation of electrolytes, although at the time volume 
replacement and oxygen carrying capacity were prioritised. The 
dog’s young age may have contributed to him tolerating such a 
significant physiological stress well. Volume replacement was only 
just adequate, and in hindsight the dog should have received 
whole blood, with closer attention paid to electrolyte levels. CA  
Conflict of interest: no conflict.
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